Search Results - Markus Warmuth
- Showing 1 - 20 results of 29
- Go to Next Page
-
1
-
2
Loss of function JAK1 mutations occur at high frequency in cancers with microsatellite instability and are suggestive of immune evasion by Lee A. Albacker, Jeremy Wu, Peter Smith, Markus Warmuth, Philip J. Stephens, Ping Zhu, Lihua Yu, Juliann Chmielecki
Published 2017Artigo -
3
Dual-specific Src and Abl kinase inhibitors, PP1 and CGP76030, inhibit growth and survival of cells expressing imatinib mesylate–resistant Bcr-Abl kinases by Markus Warmuth, Nicola Simon, Olga Mitina, Ruth Mathes, Doriano Fabbro, Paul W. Manley, Elisabeth Buchdunger, Karin Forster, Ismail Moarefi, Michael Hallek
Published 2002Artigo -
4
Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia by Yiguo Hu, Yuhua Liu, Shawn D. Pelletier, Elisabeth Buchdunger, Markus Warmuth, Doriano Fabbro, Michael Hallek, Richard A. Van Etten, Shaoguang Li
Published 2004Artigo -
5
Expansion of Bcr-Abl-Positive Leukemic Stem Cells Is Dependent on Hedgehog Pathway Activation by Christine Dierks, Ronak Beigi, Gui-Rong Guo, Katja Zirlik, Mario Stegert, Paul W. Manley, Christopher Trussell, Annette Schmitt‐Graeff, Klemens Landwerlin, Hendrik Veelken, Markus Warmuth
Published 2008Artigo -
6
-
7
The Polycomb Group Protein Bmi-1 Is Essential for the Growth of Multiple Myeloma Cells by Zainab Jagani, Dmitri Wiederschain, Alice Loo, Dan He, Rebecca Mosher, Paul Fordjour, John E. Monahan, Michael Morrissey, Yung-Mae Yao, Christoph Lengauer, Markus Warmuth, William R. Sellers, Marion Dorsch
Published 2010Artigo -
8
The ITK-SYK Fusion Oncogene Induces a T-Cell Lymphoproliferative Disease in Mice Mimicking Human Disease by Christine Dierks, Francisco Adrián, Paul Fisch, Hong Ma, Helga Maurer, Dieter Herchenbach, Christine Ulrike Forster, Clara Sprissler, Guoxun Liu, Sabine Rottmann, Gui-Rong Guo, Katja Zirlik, Hendrik Veelken, Markus Warmuth
Published 2010Artigo -
9
NAMPT Is the Cellular Target of STF-31-Like Small-Molecule Probes by Drew Adams, Daisuke Ito, Matthew G. Rees, Brinton Seashore‐Ludlow, Xiaoling Puyang, Alex H. Ramos, Jaime H. Cheah, Paul A. Clemons, Markus Warmuth, Ping Zhu, Alykhan F. Shamji, Stuart L. Schreiber
Published 2014Carta -
10
Protein Kinase C Inhibitor Sotrastaurin Selectively Inhibits the Growth of CD79 Mutant Diffuse Large B-Cell Lymphomas by Tara L. Naylor, Huaping Tang, Boris A. Ratsch, Andreas Enns, Alice Loo, Liqing Chen, Peter Lenz, Nigel J. Waters, W. Schüler, Bernd Dörken, Yung‐Mae Yao, Markus Warmuth, Georg Lenz, Frank Stegmeier
Published 2011Artigo -
11
A Type-II Kinase Inhibitor Capable of Inhibiting the T315I “Gatekeeper” Mutant of Bcr-Abl by Hwan Geun Choi, Pingda Ren, Francisco Adrián, Fangxian Sun, Hyun Soo Lee, Xia Wang, Qiang Ding, Guobao Zhang, Yongping Xie, Jianming Zhang, Yi Liu, Tove Tuntland, Markus Warmuth, Paul W. Manley, Jürgen Mestan, Nathanael S. Gray, Taebo Sim
Published 2010Artigo -
12
Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK by Anna Galkin, Jonathan S. Melnick, Sung Joon Kim, Tami Hood, Nanxin Li, Lintong Li, Gang Xia, Ruo W. Steensma, Greg Chopiuk, Jiqing Jiang, Yongqin Wan, Peter Ding, Yi Liu, Fangxian Sun, Peter G. Schultz, Nathanael S. Gray, Markus Warmuth
Published 2006Artigo -
13
Maintenance of adenomatous polyposis coli ( <i>APC</i> )-mutant colorectal cancer is dependent on Wnt/β-catenin signaling by Alix Scholer‐Dahirel, Michael R. Schlabach, Alice Loo, Linda Bagdasarian, Ronald A. Meyer, Ribo Guo, Steve Woolfenden, Kristine Yu, Judit Markovits, Karen A. Killary, Dmitriy Sonkin, Yung‐Mae Yao, Markus Warmuth, William R. Sellers, Robert Schlegel, Frank Stegmeier, Rebecca Mosher, Margaret E. McLaughlin
Published 2011Artigo -
14
Sensitivity to splicing modulation of BCL2 family genes defines cancer therapeutic strategies for splicing modulators by Daniel Aird, Teng Teng, Chia‐Ling Huang, Ermira Pazolli, Deepti Banka, Kahlin Cheung-Ong, Cheryl Eifert, Craig Furman, Zhenhua J. Wu, Michael Seiler, Silvia Buonamici, Peter Fekkes, Craig Karr, James Palacino, Eunice Park, Peter G. Smith, Lihua Yu, Yoshiharu Mizui, Markus Warmuth, Agustin Chicas, Laura Corson, Ping Zhu
Published 2019Artigo -
15
Discovery of NVP-LDE225, a Potent and Selective Smoothened Antagonist by Shifeng Pan, Xu Wu, Jiqing Jiang, Wenqi Gao, Yongqin Wan, Cheng Dai, Dong Han, Jun Liu, Nathan Englund, Yan Wang, Stefan Peukert, Karen Miller‐Moslin, Jing Yuan, Ribo Guo, Melissa Matsumoto, Anthony Vattay, Yun Jiang, Jeffrey Tsao, Fangxian Sun, AnneMarie Culazzo Pferdekamper, Stephanie Dodd, Tove Tuntland, Wieslawa Maniara, Joseph F. Kelleher, Yung‐Mae Yao, Markus Warmuth, Juliet Williams, Marion Dorsch
Published 2010Artigo -
16
An efficient rapid system for profiling the cellular activities of molecular libraries by Jonathan S. Melnick, Jeff Janes, Sung Joon Kim, Jim Chang, Daniel G. Sipes, Drew Gunderson, Laura Jarnes, Jason Matzen, Michael Garcia, Tami Hood, Ronak Beigi, Gang Xia, Richard A. Harig, Hayk Asatryan, S. Frank Yan, Yingyao Zhou, Xiang-ju Gu, Alham Saadat, Vicki Zhou, Frederick J. King, Christopher M. Shaw, Andrew I. Su, Robert T. Downs, Nathanael S. Gray, Peter G. Schultz, Markus Warmuth, Jeremy S. Caldwell
Published 2006Artigo -
17
Splicing modulators act at the branch point adenosine binding pocket defined by the PHF5A–SF3b complex by Teng Teng, Jennifer Tsai, Xiaoling Puyang, Michael Seiler, Shouyong Peng, Sudeep Prajapati, Daniel Aird, Silvia Buonamici, Benjamin Caleb, Betty Chan, Laura Corson, Jacob Feala, Peter Fekkes, Baudouin Gerard, Craig Karr, Manav Korpal, Xiang Liu, Jason T. Lowe, Yoshiharu Mizui, James Palacino, Eunice Park, Peter G. Smith, Vanitha Subramanian, Zhenhua J. Wu, Jian Zou, Lihua Yu, Agustin Chicas, Markus Warmuth, Nicholas Larsen, Ping Zhu
Published 2017Artigo -
18
Interfering with Resistance to Smoothened Antagonists by Inhibition of the PI3K Pathway in Medulloblastoma by Silvia Buonamici, Juliet Williams, Michael Morrissey, Anlai Wang, Ribo Guo, Anthony Vattay, Kathy Hsiao, Jing Yuan, John Green, Beatriz Muñoz, Qunyan Yu, Lance Ostrom, Paul Fordjour, Dustin L. Anderson, John E. Monahan, Joseph F. Kelleher, Stefan Peukert, Shifeng Pan, Xu Wu, Sauveur-Michel Maira, Carlos Garcı́a-Echeverrı́a, Kimberly J. Briggs, D. Neil Watkins, Yung-Mae Yao, Christoph Lengauer, Markus Warmuth, William R. Sellers, Marion Dorsch
Published 2010Artigo -
19
Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway by Zainab Jagani, E. Lorena Mora‐Blanco, Courtney G. Sansam, Elizabeth S. McKenna, Boris G. Wilson, Dongshu Chen, Justin Klekota, Pablo Tamayo, Phuong Nguyen, Michael Tolstorukov, Peter J. Park, Yoon-Jae Cho, Kathy Hsiao, Silvia Buonamici, Scott L. Pomeroy, Jill P. Mesirov, Heinz Ruffner, Tewis Bouwmeester, Sarah J. Luchansky, Joshua Murtie, Joseph F. Kelleher, Markus Warmuth, William R. Sellers, Charles W.M. Roberts, Marion Dorsch
Published 2010Artigo -
20
Targeting Bcr–Abl by combining allosteric with ATP-binding-site inhibitors by Jianming Zhang, Francisco Adrián, Wolfgang Jahnke, Sandra W. Cowan‐Jacob, Allen G. Li, Roxana E. Iacob, Taebo Sim, John T. Powers, Christine Dierks, Fangxian Sun, Gui-Rong Guo, Qiang Ding, Okram Barun, Yongmun Choi, Amy Wojciechowski, Xianming Deng, Guoxun Liu, Gabriele Fendrich, André Strauss, Navratna Vajpai, Stephan Grzesiek, Tove Tuntland, Yi Liu, Badry Bursulaya, Mohammad Azam, Paul W. Manley, John R. Engen, George Q. Daley, Markus Warmuth, Nathanael S. Gray
Published 2010Artigo
Search Tools:
Related Subjects
Biology
Cancer research
Genetics
Cell biology
Gene
Biochemistry
Chemistry
Signal transduction
Computational biology
Receptor
Cancer
Immunology
Tyrosine kinase
Kinase
Medicine
Pharmacology
Cell culture
Hedgehog
Hedgehog signaling pathway
Imatinib
Internal medicine
Mutant
Myeloid leukemia
RNA
RNA splicing
Spliceosome
ABL
Apoptosis
Computer science
Enzyme